Corrigendum to "Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience".


Journal

Case reports in oncological medicine
ISSN: 2090-6706
Titre abrégé: Case Rep Oncol Med
Pays: United States
ID NLM: 101581035

Informations de publication

Date de publication:
Historique:
received: 28 07 2019
accepted: 23 08 2019
entrez: 28 11 2019
pubmed: 28 11 2019
medline: 28 11 2019
Statut: epublish

Résumé

[This corrects the article DOI: 10.1155/2019/3560640.].

Identifiants

pubmed: 31772797
doi: 10.1155/2019/3868790
pmc: PMC6854979
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

3868790

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2019 Vidhya Karivedu et al.

Références

Case Rep Oncol Med. 2019 Apr 17;2019:3560640
pubmed: 31179139

Auteurs

Vidhya Karivedu (V)

Department of Internal Medicine, Division of Hematology/Oncology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Ihab Eldessouki (I)

Department of Internal Medicine, Division of Hematology/Oncology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Zelia Correa (Z)

Ocular Oncology Service, Department of Ophthalmology, University of Cincinnati College of Medicine, USA.

Ahmad Taftaf (A)

Department of Internal Medicine, Division of Hematology/Oncology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Zheng Zhu (Z)

Department of Biostatistics and Bioinformatics, Department of Environmental Health, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.

Abouelmagd Makramalla (A)

Division of Vascular and Interventional Radiology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Nagla Abdel Karim (NA)

Department of Internal Medicine, Division of Hematology/Oncology, Medical College of Georgia-Augusta University, Augusta, GA, USA.

Classifications MeSH